Karyn Goodman, MD, MS, FASTRO

Dr. Karyn Goodman is Professor and Vice Chair of Research in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai and serves as Associate Director of Clinical Research in the Tisch Cancer Institute. She was previously at the University of Colorado until 2019, and head of GI Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK) until 2015. Dr. Goodman obtained her undergraduate and medical degrees from Stanford University. She completed her residency training in Radiation Oncology at MSK and earned a Masters in Epidemiology at the Harvard School of Public Health in 2006. Dr. Goodman’s interests include image-guide radiation therapy, stereotactic body radiotherapy, and intensity modulated radiotherapy treatment planning for gastrointestinal cancers with the intent of reducing toxicity and improving results with radiation therapy. She has also focused her research on quality of life and late effects after radiotherapy. She is involved in the development of therapeutic protocols combining radiation, chemotherapy, targeted agents, and immunotherapy for gastrointestinal cancers. Dr. Goodman is an internationally recognized expert in gastrointestinal cancers and has served in numerous leadership roles on multiple national committees including as the Co-Chair of the NCI’s Gastrointestinal Steering Committee. She serves as the national Radiation Oncology principal investigator of the RTOG/NRG 0848 study, a phase III trial evaluating the use of postoperative radiotherapy for pancreatic cancer and the national study chair for the CALGB/Alliance 80803 trial evaluating PET-directed therapy for esophageal cancer. She has published over 200 peer-reviewed scientific articles, review articles, and chapters.

Disclosures: